Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2017 June;69(3) > Minerva Ginecologica 2017 June;69(3):259-68

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  


Minerva Ginecologica 2017 June;69(3):259-68

DOI: 10.23736/S0026-4784.17.04041-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Contraception for women with heart disease: an update

Rogério BONASSI MACHADO 1, Ana C. GANDOLPHO 1, Narayana SANTANA 1, Rogerio C. BOCARDO 1, Nathalia PALANDRI 1, Renato MORASSUTTI MACHADO 2

1 Department of Gynecology and Obstetrics, Jundiaí Medical School, Jundiaí, São Paulo, Brazil; 2 University of Sao Caetano do Sul, Faculty of Medicine, São Paulo, Brazil


PDF  


BACKGROUND: It is estimated that by the year 2013, 303.000 women worldwide died as a result of pregnancy-related conditions. The risk of pregnancy complications in women with heart disease depends on the specific disease and on the individual conditions of each patient.
EVIDENCE ACQUISITION: A bibliographic research was carried out on PubMed using the descriptors “heart disease” AND “contraceptive” OR “pregnancy” AND “thrombosis” OR “angina” OR “cardiopathy”. A total of 1456 articles were found.
EVIDENCE SYNTHESIS: Classification of heart disease in pregnancy according to the severity of the condition include high, intermediate or low-risk cardiac patients. Tubal ligation is indicated for women with high-risk heart disease. Reversible methods are possible for intermediate or low-risk cardiac patient, but formal contraindications for estrogens are present in large percentage of clinical conditions and progestogen-only formulations are generally considered. Contraindications to the use of an intrauterine device disease should be considered.
CONCLUSIONS: According to the different forms of heart disease, different contraceptive methods are recommended.


KEY WORDS: Contraception - Contraceptives, oral, combined - Heart diseases - Heart diseases, congenital

top of page

Publication History

Issue published online: April 5, 2017
Article first published online: March 7, 2017

Cite this article as

Bonassi Machado R, Gandolpho AC, Santana N, Bocardo RC, Palandri N, Morassutti Machado R. Contraception for women with heart disease: an update. Minerva Ginecol 2017;69:259-68. DOI: 10.23736/S0026-4784.17.04041-2

Corresponding author e-mail

rogeriobonassi@terra.com.br